False Suggestion of Malignant Transformation of Benign Bone Tumor by 18F-FDG PET/CT

Chen, Yu Ren; Kuo, Yi Chun; Hsu, Cheng Nan; Hsieh, T’sang‐T’ang; Kao, Chia Hung

doi:10.1097/rlu.0000000000001368

Cited by 4 publications

(2 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Similar to our study Yi-HaoChenet al [25] studied Fourteen patients were included in our study. Patients were divided into 2 groups according to whether or not they had a history of hypertension.…”

Section: Discussionsupporting

confidence: 54%

Study of clinical and ophthalmic menefestations of malignant hypertension

Telgote

Singh²

2015

Int J Med Res Rev

View full text Add to dashboard Cite

Introduction: Malignant hypertension is high blood pressure that comes suddenly and quickly. We attempted to review the clinical and fundus findings in patients with malignant hypertension (MHT). The lower (diastolic) blood pressure reading which is normally less than 80 mmHg, is often above 130 mmHg (240/140mmHg). Malignant hypertension may present with retinopathy, choroidopathy, and optic neuropathy. Optical coherence tomography is a relatively new imaging technique for evaluating retinal thickness and the location of pathologyin patients with malignant hypertension. Material and Methods: A retrospective observational study was carried in the department of ophthalmology comprising two groups based on history of history of hypertension (group1)and no history of hypertension (group2). The charts and fundus photographs of patients with hypertensive retinopathy from 2010 to 2015 was studied. Data of patients were included when their color photographs of the fundus were judged to indicate hypertensive retinopathy grade III or IV. There had to have been at least 1 high blood pressure reading recorded in the chart during the period when the symptoms occurred. Results: Twenty patients were included in our study. Patients were divided into 2 groups according to whether or not they had a history ofhypertension. Group 1 included 8 patients with no hypertension history, while group 2 included 12 patients with a known hypertension history. In group 1, Malignant hypertension was diagnosed by an ophthalmologist in 8 patients, in which 4:4 M:F ratio and In group 2 , 12 patients of malignant hypertension, in which M:F ratio being 3:9.There were no significant differences in age, or systolic and diastolic blood pressures. There were more complications such as renal failure and stroke in group 2 patients. Conclusion: Funduscopy has decisive significance in the diagnosis and monitoring of MHT. In order to accurately diagnose and achieve early control of this critical condition, a detailed fundus examination and blood pressure monitoring are mandatory.

show abstract

Section: Discussionsupporting

confidence: 54%

Study of clinical and ophthalmic menefestations of malignant hypertension

Telgote

Singh²

2015

Int J Med Res Rev

View full text Add to dashboard Cite

show abstract

“…The utilization of 18 F-FDG PET/CT is applicable for the purposes of staging, identifying recurrence, tracking response to chemotherapy, and forecasting prognosis (43). The terms "soft tissue sarcoma" (frequency: 179), "bone tumor" (frequency: 141), "osteosarcoma" (frequency: 117), and "Ewing sarcoma" (frequency: 37) demonstrate extensive evidence of the broad indications of 18 F-FDG PET/CT in both bone sarcoma and STS (3,44,45). Further, "neoadjuvant chemotherapy" (NCT, centrality: 0.19) has the second highest centrality, demonstrating the importance of NCT for the treatment of sarcoma, and the tumor response to NCT provides us with further information relevant to each patient's biological behavior and helps to predict the ultimate oncology outcome (46,47).…”

Section: Analysis Of Abstractmentioning

confidence: 99%

A bibliometric analysis based on hotspots and frontier trends of positron emission tomography/computed tomography utility in bone and soft tissue sarcoma

Xiang,

Zhang,

Tan

et al. 2024

Front. Oncol.

View full text Add to dashboard Cite

PurposeThis study aimed to analyze articles on the diagnosis and treatment of bone and soft tissue sarcoma using positron emission tomography (PET)/computed tomography (CT) published in the last 13 years. The objective was to conduct a bibliometric analysis and identify the research hotspots and emerging trends.MethodsWeb of Science was used to search for articles on PET/CT diagnosis and treatment of bone and soft tissue sarcoma published from January 2010 to June 2023. CiteSpace was utilized to import data for bibliometric analysis.ResultsIn total, 425 relevant publications were identified. Publications have maintained a relatively stable growth rate for the past 13 years. The USA has the highest number of published articles (139) and the highest centrality (0.35). The UDICE-French Research Universities group is the most influential institution. BYUN BH is a prominent contributor to this field. The Journal of Clinical Oncology has the highest impact factor in the field.ConclusionThe clinical application of PET/CT is currently a research hotspot. Upcoming areas of study concentrate on the merging of PET/CT with advanced machine learning and/or alternative imaging methods, novel imaging substances, and the fusion of diagnosis and therapy. The use of PET/CT has progressively become a crucial element in the identification and management of sarcomas. To confirm its efficacy, there is a need for extensive, multicenter, prospective studies.

show abstract